A comparison of the safety and efficacy of twice daily brimonidine 0.2% versus betaxolol 0.25% in subjects with elevated intraocular pressure
- 30 November 1996
- journal article
- clinical trial
- Published by Elsevier in Survey of Ophthalmology
- Vol. 41, S39-S47
- https://doi.org/10.1016/s0039-6257(96)82030-3
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Effects of Brimonidine on Aqueous Humor Dynamics in Human EyesArchives of Ophthalmology (1950), 1995
- Short-term Efficacy of Apraclonidine Hydrochloride Added to Maximum-tolerated Medical Therapy for GlaucomaAmerican Journal of Ophthalmology, 1995
- Clinical Experience With the Long-term Use of 1% ApraclonidineArchives of Ophthalmology (1950), 1995
- The Cardiovascular, Pulmonary, and Ocular Hypotensive Effects of 0.2% BrimonidineArchives of Ophthalmology (1950), 1995
- Comparison of Apraclonidine and Timolol in Chronic Open-angle GlaucomaOphthalmology, 1993
- Effect of Apraclonidine on Intraocular Pressure in Glaucoma Patients Receiving Maximally Tolerated MedicationsJournal of Glaucoma, 1992
- Short-term Effects of Unilateral 1% Apraclonidine TherapyArchives of Ophthalmology (1950), 1988
- The Safety and Efficacy of Topical 1% ALO 2145 (p-Aminoclonidine Hydrochloride) in Normal VolunteersArchives of Ophthalmology (1950), 1987
- Interim Report: National Registry of Possible Drug-induced Ocular Side EffectsOphthalmology, 1980
- Average Partial Association in Three-Way Contingency Tables: A Review and Discussion of Alternative TestsInternational Statistical Review, 1978